Small cell transformation in crizotinib‐resistant ROS1 ‐rearranged non‐small cell lung cancer with retention of ROS1 fusion: A case report-Reference-Cited by-同舟云学术

Small cell transformation in crizotinib‐resistant ROS1 ‐rearranged non‐small cell lung cancer with retention of ROS1 fusion: A case report

Published:2021-10-08 Issue:22 Volume:12 Page:3068-3071
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thorac Cancer

Author:

Wu Chi‐Hao¹,Su Po‐Lan¹^ORCID,Hsu Che‐Wei²^ORCID,Chu Chang‐Yao³,Lin Chien‐Chung¹⁴⁵

Affiliation:

1. Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine National Cheng Kung University Tainan Taiwan

2. Department of Pathology National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University Tainan Taiwan

3. Department of Pathology Chi Mei Medical Center Tainan Taiwan

4. Institute of Clinical Medicine National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University Tainan Taiwan

5. Department of Biochemistry and Molecular Biology, College of Medicine National Cheng Kung University Tainan Taiwan

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.14175

Reference13 articles.

1. Novel Targets in Non-Small Cell Lung Cancer: ROS1 and RET Fusions

2. Crizotinib in ROS1-Rearranged Non–Small-Cell Lung Cancer

3. Patterns of metastatic spread and mechanisms of resistance to Crizotinib in ROS1‐positive non‐small‐cell lung cancer;Gainor JF;JCO Precis Oncol,2017

4. Transformation to neuroendocrine carcinoma as a resistance mechanism to lorlatinib

5. Small Cell Lung Cancer Transformation as a Resistance Mechanism to Osimertinib in Epidermal Growth Factor Receptor-Mutated Lung Adenocarcinoma: Case Report and Literature Review

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ROS1-Rearranged Lung Adenocarcinoma: From Molecular Genetics to Target Therapy;Onco;2023-08-22

2. Importance of ROS1 fene fusions in non-small cell lung cancer;Cancer Drug Resistance;2023

3. Morphologic-Molecular Transformation of Oncogene Addicted Non-Small Cell Lung Cancer;International Journal of Molecular Sciences;2022-04-09

4. Histologic transformation in lung cancer: when one door shuts, another opens;Therapeutic Advances in Medical Oncology;2022-01

5. Antineoplastics;Reactions Weekly;2022-01